Tenon Medical, Inc.
$0.8
▲
1.46%
2026-04-21 09:51:01
www.tenonmed.com
NCM: TNON
Explore Tenon Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.06 M
Current Price
$0.8
52W High / Low
$2.48 / $0.64
Stock P/E
—
Book Value
$0.18
Dividend Yield
—
ROCE
-169.5%
ROE
-2.28%
Face Value
—
EPS
$-1.7
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
26
Beta
1.25
Debt / Equity
2.8
Current Ratio
2.11
Quick Ratio
1.78
Forward P/E
-1.23
Price / Sales
2.2
Enterprise Value
$8.15 M
EV / EBITDA
-0.69
EV / Revenue
2.07
Rating
None
Target Price
$2.75
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PAVmed Inc. | $9.44 | 150.27 | $60.26 M | — | -89.22% | -32.34% | $28.44 / $6 | $10.01 |
| 2. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 3. | Aethlon Medical, Inc. | $2.39 | — | $3.67 M | — | -171.08% | -2.09% | $35.2 / $1.36 | $6.9 |
| 4. | Varex Imaging Corporation | $11.97 | — | $501.54 M | — | 7.18% | -12.9% | $14.56 / $6.76 | $11.38 |
| 5. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 6. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 7. | Cytek Biosciences, Inc. | $4.57 | — | $592.62 M | — | -10.52% | -18.05% | $6.18 / $2.37 | $2.66 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.48 M | 1.17 M | 0.56 M | 0.73 M | 0.77 M | — |
| Operating Profit | -2.87 M | -3.39 M | -2.86 M | -3.68 M | -3.17 M | — |
| Net Profit | -2.83 M | -3.34 M | -2.77 M | -3.62 M | -3.09 M | — |
| EPS in Rs | -0.25 | -0.3 | -0.25 | -0.32 | -0.27 | -3.63 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.94 M | 3.28 M | 2.93 M | 0.69 M |
| Operating Profit | -12.79 M | -13.77 M | -15.73 M | -18.73 M |
| Net Profit | -12.56 M | -13.67 M | -15.58 M | -18.92 M |
| EPS in Rs | -1.11 | -1.21 | -1.38 | -1.67 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.76 M | 9.84 M | 6.34 M | 11.09 M |
| Total Liabilities | 5.72 M | 3.87 M | 5.57 M | 4.84 M |
| Equity | 5.04 M | 5.97 M | 0.78 M | 6.25 M |
| Current Assets | 6.77 M | 8.21 M | 3.89 M | 9.35 M |
| Current Liabilities | 3.21 M | 1.87 M | 3.14 M | 2.53 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.74 M | -9.88 M | -12.18 M | -12.03 M |
| Investing CF | -1.02 M | -0.19 M | 6.14 M | -2.88 M |
| Financing CF | 8.99 M | 14.12 M | 6.3 M | 14.11 M |
| Free CF | -11.02 M | -10.06 M | -12.54 M | -12.87 M |
| Capex | -0.27 M | -0.19 M | -0.36 M | -0.85 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.92% | 323.73% | — | — |
| Earnings Growth % | 12.25% | 17.63% | — | — |
| Profit Margin % | -417.24% | -532.14% | -2737.63% | — |
| Operating Margin % | -420.08% | -537.12% | -2709.84% | — |
| Gross Margin % | 52.21% | 42.38% | -92.76% | — |
| EBITDA Margin % | -396.22% | -516.87% | -2644.57% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-09-06 | 1:0.125 |
| 2023-11-02 | 1:0.1 |